JPRN-UMIN000039887招募中未知
Evaluation of the efficacy of molecular targeted drugs using biopsy samples in patients with advanced hepatocellular carcinoma - Evaluation of the efficacy of molecular targeted drugs using biopsy samples in patients with advanced hepatocellular carcinoma
Department of Gastroenterology and Metabolism, Hiroshima University Hospital0 个研究点目标入组 50 人开始时间: 2020年3月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with allergy to lenvatinib, sorafenib, bevacizumab, atezolizumab, local anesthetics, or analgesics Patients with severe ascites, severe renal failure, severe anemia, severe thrombocytopenia, jaundice, or coagulation disorder Patients who need to take anticoagulants or anti-platelet drugs continuously Patients with severe cognitive dysfunction or psychiatric disorders Patients with severe heart failure Pregnant or nursing mothers, woman who desire to bear children
研究者
相似试验
招募中
不适用
The efficacy of molecular targeted therapy for unresectable hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000035136Kyoto University150
招募中
Unknown
Survey on the use of molecular targeted drugs for advanced hepatocellular carcinoma.hepatocellular carcinomaJPRN-UMIN000050223Other100
招募中
4 期
HeberproGen StudyDiabetic foot ulcers.RPCEC00000117Center for Genetic Engineering and Biotechnology (CIGB).156
招募中
不适用
Combination of molecularly-targeted therapy with stereotactic body radiotherapy in hepatocellular carcinoma with major vascular invasioHepatocellular carcinoma with major vascular invasionJPRN-UMIN000030718Osaka International Cancer Institute20
已完成
不适用
Study of effectiveness of a day cream product in combination with a night cream in reducing dark spots in asian adult females over a period of 3 monthsCTRI/2012/02/002420Oriflame Research and Development Ltd36